Chromatographic and mass spectrometric techniques in studies on oxidative stress in autism

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1019, Issue , 2016, Pages 4-14

  Kałuzna Czaplińska, Joanna ^a   Jóźwik Pruska, Jagoda ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Autism; Biomarkers; Chromatography; Mass spectrometry; Oxidative stress

Indexed keywords

ANTIOXIDANTS; CHROMATOGRAPHY; DISEASES; MASS SPECTROMETERS; MASS SPECTROMETRY; OXIDATIVE STRESS; SPECTROMETRY;

AUTISM; AUTISM SPECTRUM DISORDERS; CHROMATOGRAPHIC TECHNIQUES; OXIDATIVE STRESS BIOMARKERS; REACTIVE OXYGEN SPECIES; SOCIAL COMMUNICATIONS; SPECTROMETRIC METHODS; SPECTROMETRIC TECHNIQUES;

BIOMARKERS;

BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTISM; BODY FLUID; CHROMATOGRAPHY; DISEASE SEVERITY; HUMAN; MASS SPECTROMETRY; METABOLITE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RELIABILITY; BLOOD; METABOLISM; PROCEDURES;

AUTISM SPECTRUM DISORDER; BIOMARKERS; CHROMATOGRAPHY; HUMANS; MASS SPECTROMETRY; OXIDATIVE STRESS;

EID: 84952890074     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.12.035     Document Type: Article

References (96)

1. Yoshikawa T., Naito Y. What is oxidative stress?. JMAJ 2002, 45:271-276.
2. Stohs S.J. The role of free radicals in toxicity and disease. J. Basic Clin. Physiol. Pharmacol. 1995, 6:205-228.
3. Granot E., Kohen R. Oxidative stress in childhood-in health and disease states. Clin. Nutr. 2004, 23:3-11.
4. Sies H. Oxidative Stress 1985, Academic Press, New York.
5. Gutteridge J.M.C. The protective action of superoxide dismutase on metal-ion catalysed peroxidation of phospholipids. Biochem. Biophys. Res. Commun. 1977, 77:379-386.
6. Vendemiale G., Grattagliano I., Altomare E. An update on the role of free radicals and antioxidant defense in human disease. J. Clin. Lab. Res. 1999, 29:49-55.
7. Gutteridge J.M.C., Richmond R., Halliwell B. Oxygen freeradicals and lipid peroxidation. Inhibition by the protein ceruloplasmin. FEBS Lett. 1980, 112:269-272.
8. Loeffler D.A., Connor J.R., Juneau P.L., Snyder B.O.S., Kanaley L., DeMaggio A.J., Nguyen H., Brickman C.M., Lewitt P.A. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 1995, 65:710-716.
9. Erden-Inal M., Sunal E., Kanbak G. Age-related changes in the glutathione redox system. Cell. Biochem. Funct. 2002, 20:61-66.
10. Yao J.K., Reddy R.D., van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 2001, 15:287-310.
11. Kałuzna-Czaplińska J., Grys W., Szymańska A., Rynkowski J. Rola stresu oksydacyjnego w autyzmie. Borgis - Nowa Pediatria 2008, 4:67-70.
12. Shulman R.G., Rothman D.L., Behar K.L., Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004, 27:489-495.
13. Juurlink B.H., Paterson P.G. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J. Spinal Cord. Med. 1998, 21:309-334.
14. Perry S.W., Norman J.P., Litzburg A., Gelbard H.A. Antioxidants are required during the early critical period, but not later, for neuronal survival. J. Neurosci. Res. 2004, 78:485-492.
15. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torre E.F., Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9:684-697.
16. Abdalla D.S.P., Monteiro H.P., Oliveira J.A.C., Bechara E.J. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin. Chem. 1986, 32:805-807.
17. Kuloglu M., Atmaca M., Tezcan E., Ustundag B., Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 2002, 46:186-189.
18. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64:43-51.
19. American Psychiatric Association , Diagnostic and Statistical Manual of Mental Disorders, fifth ed., VA: American Psychiatric Association Arlington, 2013.
20. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13:171-181.
21. Goldani A.A., Downs S.R., Widjaja F., Lawton B., Hendren R.L. Biomarkers in autism. Front. Psychiatry 2014, 5.
22. Gorrindo P., Lane C.J., Lee E.B., McLaughlin B., Levitt P. Enrichment of elevated plasma F2t-isoprostane levels in individuals with autism who are stratified by presence of gastrointestinal dysfunction. PLoS One 2013, 8:e68444.
23. Biomarkers Definition Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95.
24. Strimbu K., Tavel J.A. What are biomarkers?. Curr. Opin. HIV AIDS 2010, 5:463-466.
25. WHO. International Programme on Chemical Safety Biomarkers and Risk Assessment: Concepts and Principles, 1993. Retrieved from . http://www.inchem.org/documents/ehc/ehc/ehc155.htm.
26. Schrattenholz A., Groebe K. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers. Electrophoresis 2007, 28:1970-1979.
27. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., Djoumbou Y., Mandal R., Aziat F., Dong E., Bouatra S., Sinelnikov I., Arndt D., Xia J., Liu P., Yallou F., Bjorndahl T., Perez-Pineiro R., Eisner R., Allen F., Neveu V., Greiner R., Scalbert A. HMDB 3.0 -The Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41:D801-D807.
28. Davies K.J. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 1995, 61:1-31.
29. Filomeni G., Ciriolo M.R. Redox control of apoptosis: an update. Antioxid Redox Signal 2006, 8:2187-2192.
30. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 2008, 11:851-876.
31. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., Neubrander J.A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80:1611-1617.
32. Jain S.K. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 1984, 259:3391-3394.
33. De La Fuente M., Miquel J., Catalán M.P., Víctor V.M., Guayerbas N. The amount of thiolic antioxidant ingestion needed to improve several immune functions is higher in aged than in adult mice. Free Radic. Res. 2002, 36:119-126.
34. De la Fuente M., Victor V.M. Ascorbic acid and N-acetylcysteine improve in vitro the function of lymphocytes from mice with endotoxin-induced oxidative stress. Free Radic. Res. 2001, 35:73-84.
35. McGinnis W.R. Oxidative stress in autism. Altern. Ther. Health Med. 2004, 10:22-36.
36. Surtees R. Cobalaminand folate responsive disorders 2001, Baxter P, Mac Keith Press London.
37. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., Neubrander J.A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80:1611-1617.
38. James S.J., Melnyk S., Jernigan S., Cleves M.A., Halsted C.H., Wong D.H., Cutler P., Bock K., Boris M., Bradstreet J.J., Baker S.M., Gaylor D.W. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:947-956.
39. Frye R.E., James S.J. Metabolic pathology of autism in relation to redox metabolism. Biomark Med. 2014, 8:321-330.
40. Herbert M.R. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr. Opin. Neurol. 2010, 23:103-110.
41. Rose S., Melnyk S., Pavliv O., Bai S., Nick T.G., Frye R.E., James S.J. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry 2012, 2:e134.
42. James S.J., Melnyk S., Fuchs G., Reid T., Jernigan S., Pavliv O., Hubanks A., Gaylor D.W. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am. J. Clin. Nutr. 2009, 89:425-430.
43. Melnyk S., Fuchs G.J., Schulz E., Lopez M., Kahler S.G., Fussell J.J., Bellando J., Pavliv O., Rose S., Seidel L., Gaylor D.W., James S.J. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J. Autism Dev. Disord. 2012, 42:367-377.
44. Bald E., Kaniowska E., Chwatko G., Głowacki R. Liquid chromatographic assessment of total and protein-bound homocysteine in human plasma. Talanta 2000, 50:1233-1243.
45. Zinellu A., Sotgia S., Usai M.F., Zinellu E., Posadino A.M., Gaspa L., Chessa R., Pinna A., Carta F., Deiana L., Carru C. Plasma methionine determination by capillary electrophoresis-UV assay: application on patients affected by retinal venous occlusive disease. Anal. Biochem. 2007, 363:91-96.
46. Miller A.M., Kelly G.S. Methionine and homocysteine metabolism and the nutritional prevention of certain birth defects and complications of pregnancy. Altern. Med. Rev. 1996, 4:220-235.
47. Sajous L., Botta A., Sari-Minodier I. Urinary 8-hydroxy-2'-deoxyguanosine: a biomarker of environmental oxidative stress?. Ann. Biol. Clin. 2008, 66:19-29.
48. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:9383-9387.
49. Montuschi P., Barnes P.J., Roberts 2nd L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800.
50. Pryor W.A., Stanely J.P., Blair E. Autoxidation of polyunsaturated fatty acids. II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 1976, 11:370-379.
51. Morrow J.D., Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 1997, 36:1-21.
52. Syslová K., Böhmová A., Mikoška M., Kuzma M., Pelclová D., Kačer P. Multimarker screening of oxidative stress in aging. Oxid. Med. Cell. Longev. 2014, 2014(562860).
53. Frye R.E., Delatorre R., Taylor H., Slattery J., Melnyk S., Chowdhury N., James S.J. Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl. Psychiatry 2013, 3. e273.
54. Gaut J.P., Byun J., Tran H.D., Heinecke J.W. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 2002, 300:252-259.
55. Frost M.T., Halliwell B., Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem. J. 2000, 345:453-458.
56. Chauhan A., Chauhan V., Brown W.T., Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci. 2004, 75:2539-2549.
57. Karl H., Smith B.S.W., Wright H.H. Colorimetric method for serum ceruloplasmin. Clin. Chem. 1974, 50:359-366.
58. Buglanov A.A., Saiapina E.V., Aver'ianova A.A. Determination of the ironbinding capacity and transferrin in blood. Lab Delo. 1991, 6:24-26.
59. Ragini M., Banji O., Banji D., Pratusha G., Kumar K., Ananthula M.R. Biomarkers in Autism. Int. J. Pharm. Tech. Res. 2011, 3:1281-1289.
60. Tórsdóttir G., Hreidarsson S., Kristinsson J., Snaedal J., Jóhannesson T. Ceruloplasmin, superoxide dismutase and copper in autistic patients. Basic Clin. Pharmacol. Toxicol. 2005, 96:146-148.
61. Golse B., Debray-Ritzen P., Durosay P., Puget K., Michelson A.M. Alterations in two enzymes: superoxide dismutase and glutathione peroxidase in developmental infantile psycosis (infantile autism). Revue. Neurologique. 1978, 134:699-705.
62. Yorbik O., Sayal A., Akay C., Akbiyik D.I., Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67:341-343.
63. Söğüt S., Zoroğlu S.S., Ozyurt H., Yilmaz H.R., Ozuğurlu F., Sivasli E., Yetkin O., Yanik M., Tutkun H., Savaş H.A., Tarakçioğlu M., Akyol O. Changes in nitric oxide levels and antioxidant enzyme activities may have role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta 2003, 331:111-117.
64. Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R., Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 1997, 43:1209-1214.
65. Meguid N.A., Dardir A.A., Abdel-Raouf E.R., Hashish A. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol. Trace Elem. Res. 2011, 143:58-65.
66. Adams J.B., Audhya T., McDonough-Means S., Rubin R.A., Quig D., Geis E., Gehn E., Loresto M., Mitchell J., Atwood S., Barnhouse S., Lee W. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr. Metab. (Lond.) 2011, 8:34.
67. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
68. McDowall B. Why system suitability tests are not a substitute for analytical instrument qualification or calibration (Part 2). LCGC Europe 2010, 23:585.
69. Masson P. Quality control techniques for routine analysis with liquid chromatography in laboratories. J. Chromatogr. A 2007, 1158:168-173.
70. Meguid N.A., Dardir A.A., Abdel-Raouf E.R., Hashish A. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol. Trace Elem. Res. 2011, 143:58-65.
71. El-Ansary A., Al-Ayadhi L. Lipid mediators in plasma of autism spectrum disorders. Lipids Health Dis. 2012, 11:160.
72. González-Fraguela M.E., Diaz Hung M.-L., Vera H., Maragoto C., Noris E., Blanco L., Galvizu R., Robinson M. Oxidative Stress Markers in Children with Autism Spectrum Disorders. Br. J. Med. Med. Res. 2013, 3:307-317.
73. Pagan C., Delorme R., Callebert J., Goubran-Botros H., Amsellem F., Drouot X., Boudebesse C., Le Dudal K., Ngo-Nguyen N., Laouamri H., Gillberg C., Leboyer M., Bourgeron T., Launay J.M. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl. Psychiatry 2014, 4:e479.
74. Faust T. Amicable separations. Nature Milestones: Mass Spectrometry 2015, 10-11.
75. Pullen F. The fascinating history of the development of LC-MS; a personal perspective. Chromatography Today 2010, 4-6.
76. Jellum E., Stokke O., Eldjarn L. Application of gas chromatography, mass spectrometry, and computer methods in clinical biochemistry. Anal. Chem. 1973, 46:1099-1106.
77. Evenson M.A., Carmack G.D. Clinical chemistry. Anal. Chem. 1979, 51:35-79.
78. Kałuzna-Czaplińska J., Jóźwik J. Current applications of chromatographic methods for diagnosis and identification of potential biomarkers in cancer. TrAC 2014, 56:1-12.
79. Grebe S.K., Singh R.J. LC-MS/MS in the clinical laboratory-where to from here. Clin. Biochem. Rev. 2011, 32:5-31.
80. Kałuzna-Czaplińska J., Michalska M., Rynkowski J. Homocysteine level in urine of autistic and healthy children. Acta Biochim. Pol. 2011, 58:31-34.
81. Kałuzna-Czaplińska J., Michalska M., Rynkowski J. Vitamin supplementation reduces the level of homocysteine in the urine of autistic children. Nutr. Res. 2011, 31:318-321.
82. Shimmura C., Suda S., Tsuchiya K.J., Hashimoto K., Ohno K., Matsuzaki H., Iwata K., Matsumoto K., Wakuda T., Kameno Y., Suzuki K., Tsujii M., Nakamura K., Takei N., Mori N. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 2011, 6:e25340.
83. Naushad S.M., Jain J.M., Prasad C.K., Naik U., Akella R.R. Autistic children exhibit distinct plasma amino acid profile. Indian J. Biochem. Biophys. 2013, 50:474-478.
84. Shinohe A., Hashimoto K., Nakamura K., Tsujii M., Iwata Y., Tsuchiya K.J., Sekine Y., Suda S., Suzuki K., Sugihara G., Matsuzaki H., Minabe Y., Sugiyama T., Kawai M., Iyo M., Takei N., Mori N. Increased serum levels of glutamate in adult patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1472-1477.
85. Kałuzna-Czaplinska J., Michalska M., Rynkowski J. Determination of tryptophan in urine of autistic and healthy children by gas chromatography/mass spectrometry. Med. Sci. Monit. 2010, 16:CR488-CR492.
86. Ciccoli L., De Felice C., Paccagnini E., Leoncini S., Pecorelli A., Signorini C., Belmonte G., Guerranti R., Cortelazzo A., Gentile M., Zollo G., Durand T., Valacchi G., Rossi M., Hayek J. Erythrocyte shape abnormalities, membrane oxidative damage, and β-actin alterations: an unrecognized triad in classical autism. Mediators Inflamm. 2013, 2013. 432616.
87. Yao Y., Walsh W.J., McGinnis W.R., Praticò D. Altered vascular phenotype in autism: correlation with oxidative stress. Arch. Neurol. 2006, 63:1161-1164.
88. Kern J.K., Geier D.A., Adams J.B., Mehta J.A., Grannemann B.D., Geier M.R. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr. Int. 2011, 53:147-153.
89. Lawson J.A., Brash A.R., Doran J., FitzGerald G.A. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative-ion chemical ionization mass spectrometry. Anal. Biochem. 1985, 150:463-470.
90. Milne G.L., Sanchez S.C., Musiek E.S., Morrow J.D. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2007, 2:221-226.
91. Morrow J.D., Roberts 2nd L.J. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 1999, 300:3-12.
92. Tsikas D., Duncan M.W. Mass spectrometry and 3-nitrotyrosine: strategies, controversies, and our current perspective. Mass Spectrom. Rev. 2014, 33:237-276.
93. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit. Rev. Clin. Lab Sci. 2009, 46:241-281.
94. Tsikas D., Suchy M.T., Niemann J., Tossios P., Schneider Y., Rothmann S., Gutzki F.M., Frölich J.C., Stichtenoth D.O. Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2α. FEBS Lett. 2012, 586:3723-3730.
95. Childs A., Jacobs C., Kaminski T., Halliwell B., Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic. Biol. Med. 2001, 31:745-753.
96. Collins A.R., Cadet J., Möller L., Poulsen H.E., Viña J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Arch. Biochem. Biophys. 2004, 423:57-65.